E S Woodle

Summary

Affiliation: University of Cincinnati
Country: USA

Publications

  1. ncbi request reprint A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus
    E Steve Woodle
    Division of Transplantation, Department of Surgery, University of Cincinnati, School of Medicine, Cincinnati, OH, USA
    Am J Transplant 5:157-66. 2005
  2. ncbi request reprint Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens
    E S Woodle
    Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:809-11. 2005
  3. ncbi request reprint Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression
    E Steve Woodle
    Division of Transplantation, University of Cincinnati, Cincinnati, OH, USA
    Am J Transplant 5:2740-4. 2005
  4. doi request reprint A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation
    E Steve Woodle
    Division of Transplantation, Department of Surgery, University of Cincinnati, Cincinnati, OH, USA
    Clin Transplant 24:73-83. 2010
  5. ncbi request reprint Ethical considerations for participation of nondirected living donors in kidney exchange programs
    E S Woodle
    The Paired Donation Network, Orlando, FL, USA
    Am J Transplant 10:1460-7. 2010
  6. ncbi request reprint A prospective, randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: one year report
    E S Woodle
    Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:804-8. 2005
  7. ncbi request reprint A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy
    E Steve Woodle
    Division of Transplantation, Department of Surgery, University of Cincinnati, Cincinnati, OH 45267, USA
    Ann Surg 248:564-77. 2008
  8. ncbi request reprint Influence of educational programs on perceived barriers toward living donor kidney exchange programs
    E S Woodle
    Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 95249, USA
    Transplant Proc 37:602-4. 2005
  9. doi request reprint Proteasome inhibitor treatment of antibody-mediated allograft rejection
    E Steve Woodle
    Division of Transplantation, Department of Surgery, Hoxworth Blood Center, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA
    Curr Opin Organ Transplant 16:434-8. 2011
  10. doi request reprint Proteasome inhibitor therapy for antibody-mediated rejection
    E S Woodle
    Department of Surgery, University of Cincinnati, Cincinnati, OH, USA
    Pediatr Transplant 15:548-56. 2011

Collaborators

Detail Information

Publications97

  1. ncbi request reprint A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus
    E Steve Woodle
    Division of Transplantation, Department of Surgery, University of Cincinnati, School of Medicine, Cincinnati, OH, USA
    Am J Transplant 5:157-66. 2005
    ....
  2. ncbi request reprint Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens
    E S Woodle
    Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:809-11. 2005
    ..The purpose of this study was to evaluate the ability of histocompatibility testing to identify patients at high risk for acute rejection after early CSWD...
  3. ncbi request reprint Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression
    E Steve Woodle
    Division of Transplantation, University of Cincinnati, Cincinnati, OH, USA
    Am J Transplant 5:2740-4. 2005
    ....
  4. doi request reprint A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation
    E Steve Woodle
    Division of Transplantation, Department of Surgery, University of Cincinnati, Cincinnati, OH, USA
    Clin Transplant 24:73-83. 2010
    ....
  5. ncbi request reprint Ethical considerations for participation of nondirected living donors in kidney exchange programs
    E S Woodle
    The Paired Donation Network, Orlando, FL, USA
    Am J Transplant 10:1460-7. 2010
    ..Recent occurrences of BDs backing out argue for adoption of ethically based protective measures for NDD participation in KE...
  6. ncbi request reprint A prospective, randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: one year report
    E S Woodle
    Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:804-8. 2005
    ..0%), and improved CHD risk profile at 1 year posttransplantation...
  7. ncbi request reprint A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy
    E Steve Woodle
    Division of Transplantation, Department of Surgery, University of Cincinnati, Cincinnati, OH 45267, USA
    Ann Surg 248:564-77. 2008
    ..To compare outcomes with early corticosteroid withdrawal (CSWD) and chronic low dose corticosteroid therapy (CCS)...
  8. ncbi request reprint Influence of educational programs on perceived barriers toward living donor kidney exchange programs
    E S Woodle
    Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 95249, USA
    Transplant Proc 37:602-4. 2005
    ..The aim of this study was to examine the effect of an educational conference on perceived barriers toward living donor kidney transplantation and LDKEPs...
  9. doi request reprint Proteasome inhibitor treatment of antibody-mediated allograft rejection
    E Steve Woodle
    Division of Transplantation, Department of Surgery, Hoxworth Blood Center, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA
    Curr Opin Organ Transplant 16:434-8. 2011
    ..The purpose of this review is to provide an update of recent basic science and clinical results with bortezomib in treating antibody-mediated rejection (AMR) that occurs in solid organ transplant recipients...
  10. doi request reprint Proteasome inhibitor therapy for antibody-mediated rejection
    E S Woodle
    Department of Surgery, University of Cincinnati, Cincinnati, OH, USA
    Pediatr Transplant 15:548-56. 2011
    ..These results demonstrate the significant potential of proteasome inhibition in addressing humoral barriers. However, the major advantage of proteasome inhibition lies in the numerous potential strategies for achieving synergy...
  11. ncbi request reprint Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: multivariate analysis of risk factors for acute rejection
    E S Woodle
    Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:798-9. 2005
    ..We have accumulated enough high-risk patients with early withdrawal to allow the first multivariate analysis of risk factors for acute rejection in early withdrawal under modern immunosuppression...
  12. ncbi request reprint Pilot study of early corticosteroid elimination after pancreas transplantation
    M J Hanaway
    University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:1287-8. 2005
    ..In the present study, we provide evidence that early withdrawal can be achieved in pancreas as well as pancreas-kidney recipients...
  13. ncbi request reprint A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience
    R R Alloway
    Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:802-3. 2005
    ..The first prospective trial of steroid withdrawal dedicated to high-immunologic-risk patients is reported herein...
  14. ncbi request reprint Proteasome inhibition reduces donor-specific antibody levels
    M J Everly
    University of Cincinnati College of Medicine, and The Christ Hospital, Cincinnati, OH 45267 0558, USA
    Transplant Proc 41:105-7. 2009
    ..Bortezomib is approved by the US Food and Drug Administration for the treatment of plasma cell tumors (multiple myeloma)...
  15. ncbi request reprint Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience
    J F Buell
    University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:956-7. 2005
    ..The purpose of the study was to review the Israel Penn International Transplant Tumor Registry experience with PTLD treated with chemotherapy...
  16. ncbi request reprint Outcomes of patients with rejection post-polyomavirus nephropathy
    J Trofe
    Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, Ohio, USA
    Transplant Proc 37:942-4. 2005
    ..We sought to determine the effects of rejection in renal transplant recipients with polyomavirus nephropathy (PVN)...
  17. ncbi request reprint Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation
    C C Rogers
    Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:812-3. 2005
    ..The purpose of this study was to document cardiovascular risk under CSWD using a global risk assessment by Framingham risk assessment...
  18. ncbi request reprint De novo sarcomas in solid organ transplant recipients
    T L Husted
    Israel Penn International Transplant Tumor Registry, Division of Transplantation, The University of Cincinnati Medical School, 231 Albert Sabin Way, Cincinnati, OH 45267 0558, USA
    Transplant Proc 34:1786-7. 2002
  19. ncbi request reprint Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience
    E S Woodle
    University of Cincinnati, Cincinnati, Ohio, USA
    Transplant Proc 37:958-9. 2005
    ..To date, reported experiences with transplantation in men with a history of PCA are limited to only a few patients. This study presents the first series of transplant recipients with a history of PCA...
  20. doi request reprint Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss
    M J Everly
    Department of Surgery, Transplantation Division, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    Am J Transplant 9:1063-71. 2009
    ..039). De novo DSAs detected at rejection are associated with reduced allograft survival, but prompt DSA reduction was associated with improved allograft survival. DSA should be considered a potential new end point for rejection therapy...
  21. ncbi request reprint Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney transplant recipients
    N S Ejaz
    Division of Transplantation, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH
    Am J Transplant 13:3142-54. 2013
    ..In conclusion, addition of rituximab and/or bortezomib to rATG induction has an acceptable safety/toxicity profile in a high immunologic risk renal transplant population...
  22. ncbi request reprint Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis
    R Boardman
    University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:817-8. 2005
    ....
  23. ncbi request reprint Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality
    J F Buell
    University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:583-4. 2005
    ..The cost of misdiagnosis of central nervous system (CNS) tumors in donors has not been previously described. The purpose of this study was to examine the Israel Penn International Transplant Tumor Registry experience with these donors...
  24. ncbi request reprint Transmission of donor cancer into cardiothoracic transplant recipients
    J F Buell
    Israel Penn International Transplant Tumor Registry, Department of Surgery, University of Cincinnati, Ohio 45267, USA
    Surgery 130:660-6; discussion 666-8. 2001
    ....
  25. ncbi request reprint Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation
    J Wesley Alexander
    Department of Surgery, Transplantation Division, University of Cincinnati College of Medicine, OH 45267, USA
    Transpl Int 19:295-302. 2006
    ..Fifty-seven percent of 54 patients with a functioning kidney at 3 years were receiving monotherapy with RAPA. We conclude that this therapeutic strategy is worthy of a prospective multi-center clinical trial...
  26. ncbi request reprint Transplantation without steroids
    J W Alexander
    Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    Transplant Proc 34:2076-8. 2002
  27. ncbi request reprint OKT3 escalating dose regimens provide effective therapy for renal allograft rejection
    E S Woodle
    Department of Surgery, University of Chicago, Illinois 60637, USA
    Clin Transplant 10:389-95. 1996
    ....
  28. ncbi request reprint Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy
    C C Rogers
    Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45267 0558, USA
    Transplant Proc 37:795-7. 2005
    ..To evaluate the possibility that RAPA and CS have additive effects on wound healing, we evaluated the effects of corticosteroid avoidance (CSAV) on wound healing complications in patients treated with RAPA...
  29. ncbi request reprint Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring
    Jennifer Trofe
    Department of Surgery, Division of Transplantation, The University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267 0558, USA
    Transplant Proc 34:1788-9. 2002
  30. ncbi request reprint Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression
    C C Rogers
    University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:800-1. 2005
    ..The purpose of our study was to compare patterns of weight gain under chronic corticosteroid therapy (CCST) to those observed under early corticosteroid withdrawal (CSWD) in renal transplant recipients...
  31. ncbi request reprint Laparoscopic right living donor nephrectomy
    T L Husted
    University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:631-2. 2005
    ..The purpose of this study was to compare results between right and left LDN and thereby determine whether substantial experience with right LDN can provide results equivalent to left LDN...
  32. ncbi request reprint Posttransplant lymphoproliferative disorder: significance of central nervous system involvement
    J F Buell
    Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:954-5. 2005
    ..The purpose of this study was to review the Israel Penn International Transplant Tumor Registry (IPITTR) experience with CNS involvement by PTLD...
  33. doi request reprint Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients
    R Ferguson
    Ohio State University College of Medicine, Columbus, OH, USA
    Am J Transplant 11:66-76. 2011
    ....
  34. ncbi request reprint Donor kidneys with small renal cell cancers: can they be transplanted?
    J F Buell
    University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:581-2. 2005
    ..The purpose of this study was to determine whether incidentally discovered, small renal cell cancers (RCC) in donor kidneys can be excised and safely transplanted...
  35. ncbi request reprint De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population
    J F Buell
    Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:960-1. 2005
    ..The purpose of the present study was to compare outcomes in de novo colorectal cancer (CRC) following solid organ transplantation to those observed in the general population (SEER) database...
  36. ncbi request reprint Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience
    J F Buell
    Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:962-3. 2005
    ..The purpose of this study was to analyze a large series of skin cancers in solid organ transplant recipients to determine their biologic behavior...
  37. ncbi request reprint Immunosuppression and Merkel cell cancer
    Joseph F Buell
    Israel Penn International Transplant Tumor Registry, Division of Transplantation, The University of Cincinnati Medical School, 231 Albert Sabin Way, Cincinnati, OH 45267 0558, USA
    Transplant Proc 34:1780-1. 2002
  38. doi request reprint Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection
    R Carlin Walsh
    Department of Surgery, Division of Transplantation, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    Transplantation 89:277-84. 2010
    ..Our initial experience with proteasome inhibition as a first-line therapy for AMR is presented...
  39. ncbi request reprint Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression
    Christin C Rogers
    Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, OH 45267 0558, USA
    Transplantation 80:26-33. 2005
    ..e., within 7 days posttransplant) corticosteroid withdrawal (CSWD) in renal-transplant recipients...
  40. ncbi request reprint Laparoscopic live donor nephrectomy: rationale, techniques, and implications
    S R Potter
    Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, Ohio, USA
    Semin Dial 14:365-72. 2001
    ..We review the development and refinement of LDN and its current rationale and applications...
  41. ncbi request reprint Liver transplantation in the first three months of life
    E S Woodle
    Department of Surgery, University of Chicago, Illinois 60637, USA
    Transplantation 66:606-9. 1998
    ..Although infants in the first 3 months of life have not traditionally been considered a distinct age group, several features of these infants may distinguish them from other pediatric liver transplant recipients...
  42. ncbi request reprint Kidney exchange programs: attitudes of transplant team members toward living donation and kidney exchanges
    E S Woodle
    Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 95249, USA
    Transplant Proc 37:600-1. 2005
    ..The state of decision making toward LDKEP was also examined...
  43. ncbi request reprint Liver transplantation for primary or metastatic sarcoma to the liver
    T L Husted
    The Israel Penn International Transplant Tumor Registry, University of Cincinnati, Cincinnati, Ohio
    Am J Transplant 6:392-7. 2006
    ....
  44. ncbi request reprint Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study
    C R Schneider
    Division of Transplantation University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:1243-4. 2005
    ..The purpose of this study was to evaluate the clinical impact of methicillin-resistant Staphylococcus aureus (MRSA) infections on transplant recipients...
  45. ncbi request reprint Polyomavirus nephropathy in kidney transplantation
    Jennifer Trofe
    University of Cincinnati, Division of Transplantation, Ohio, USA
    Prog Transplant 14:130-40; quiz 141-2. 2004
    ..This review presents potential risk factors, screening, diagnostic and monitoring methods, therapeutic management, and retransplantation experience for polyomavirus nephropathy...
  46. doi request reprint A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation
    Jennifer K Walker
    Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, OH 45267 0585, USA
    Transplantation 87:408-14. 2009
    ..This prospective study evaluated a corticosteroid (CS)-free, calcineurin inhibitor (CNI) minimization immunosuppressive regimen in HLA-identical LD renal transplant recipients...
  47. ncbi request reprint Laparoscopic living donor nephrectomy for kidneys with multiple arteries
    T L Husted
    University of Cincinnati, Cincinnati, Ohio 45249, USA
    Transplant Proc 37:629-30. 2005
    ..The present study presents the largest series of LDN of donor kidneys with multiple arterial vessels outside of these two pioneering programs...
  48. pmc Are concerns over right laparoscopic donor nephrectomy unwarranted?
    J F Buell
    Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA
    Ann Surg 233:645-51. 2001
    ..To examine the ability of several large, experienced transplantation centers to perform right-sided laparoscopic donor nephrectomy safely with equivalent long-term renal allograft function...
  49. ncbi request reprint Gastric cancer in transplant recipients: detection of malignancy [correction of malignacy] by aggressive endoscopy
    Joseph F Buell
    Israel Penn International Transplant Tumor Registry, Division of Transplantation, The University of Cincinnati Medical School, 231 Albert Sabin Way, Cincinnati, OH 45267 0558, USA
    Transplant Proc 34:1784-5. 2002
  50. ncbi request reprint Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection
    E S Woodle
    Department of Surgery, Committee on Immunology, Ben May Institute for Cancer Research, University of Chicago, Illinois 60637, USA
    Transplantation 68:608-16. 1999
    ..This report describes the results of a phase I trial of huOKT3gamma1(Ala-Ala) treatment of acute renal allograft rejection...
  51. ncbi request reprint De novo breast cancer in renal transplant recipients
    Joseph F Buell
    Israel Penn International Transplant Tumor Registry, Division of Transplantation, The University of Cincinnati Medical School, 231 Albert Sabin Way, Cincinnati, OH 45267 0558, USA
    Transplant Proc 34:1778-9. 2002
  52. ncbi request reprint African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression
    Robyn E Boardman
    Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, OH, USA
    Am J Transplant 5:356-65. 2005
    ..Additional follow-up is needed to determine long-term renal function, graft survival, and cardiovascular risk in AAs with early CSWD...
  53. doi request reprint Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection
    Matthew J Everly
    Department of Surgery, Division of Transplantation, University of Cincinnati College of Medicine, Cincinnati, OH 45267 0558, USA
    Transplantation 86:1754-61. 2008
    ..We report the first clinical experience with plasma cell-targeted therapy (bortezomib) as an antirejection strategy...
  54. ncbi request reprint Posttransplant malignancy
    Jennifer Trofe
    Israel Penn International Transplant Tumor Registry, University of Cincinnati, Cincinnati, Ohio, USA
    Prog Transplant 14:193-200. 2004
    ..This review presents the more commonly encountered posttransplant malignancies and the measures that are currently being utilized to prevent and treat them...
  55. ncbi request reprint Basic and clinical research in polyomavirus nephropathy
    Jennifer Trofe
    Division of Transplantation, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267 0558, USA
    Exp Clin Transplant 2:162-73. 2004
    ..This review will present recent advances in basic and clinical research related to PVN and renal transplantation...
  56. ncbi request reprint Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients
    V Ram Peddi
    University of Cincinnati Medical Center, Cincinnati, Ohio 45267 0585, USA
    Transplantation 73:1514-8. 2002
    ..In view of the superior T-cell depletion and prolonged half-life of thymoglobulin, we initiated a protocol to administer thymoglobulin intermittently based on peripheral blood CD3+ lymphocyte counts...
  57. ncbi request reprint Malignancy after transplantation
    Joseph F Buell
    Israel Penn International Transplant Tumor Registry, University of Cincinnati, Cincinnati, OH 45267 0558, USA
    Transplantation 80:S254-64. 2005
    ..Long-term data are needed to determine if the use of these agents will ultimately lower the mortality due to malignancy for transplant recipients...
  58. ncbi request reprint Can immunonutrients reduce rejection rates in African Americans?
    J Wesley Alexander
    Department of Surgery, Department of Internal Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267 0585, USA
    Exp Clin Transplant 3:349-50. 2005
    ..African-American kidney allograft recipients have higher rates of rejection than do white patients. This study was performed to determine whether the use of immunonutrients may reduce the incidence of rejection in African Americans...
  59. ncbi request reprint Malignancy in pediatric transplant recipients
    Joseph F Buell
    The Israel Penn International Transplant Tumor Registry, Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45267, USA
    Semin Pediatr Surg 15:179-87. 2006
    ..This leaves transplant physicians with several new and novel immunosuppressive agents with uncertain oncologic potentials that will need to be examined over the next decade...
  60. doi request reprint Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids
    Adele H Rike
    Division of Transplantation, Department of Surgery, University of Cincinnati, Cincinnati, OH 45219, USA
    Clin Transplant 22:229-35. 2008
    ..The purpose of this study was to compare Framingham Risk Score (FRS), metabolic syndrome (MS), and cardiovascular events (CVE) in patients receiving early corticosteroid withdrawal (ECSWD), or chronic corticosteroid therapy (CCS)...
  61. ncbi request reprint Influence of long chain polyunsaturated fatty acids and ornithine concentrations on complications after renal transplant
    J Wesley Alexander
    Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    Exp Clin Transplant 6:118-26. 2008
    ....
  62. ncbi request reprint Maximizing renal artery length in right laparoscopic donor nephrectomy by retrocaval exposure of the aortorenal junction
    Joseph F Buell
    Division of Transplant Surgery, Department of Surgery, The University of Cincinnati, Cincinnati, OH 45267 0558, USA
    Transplantation 75:83-5. 2003
    ..This technique has currently been used in 20 consecutive right LDN operations without vascular complications or technical graft losses...
  63. ncbi request reprint Donors with central nervous system malignancies: are they truly safe?
    Joseph F Buell
    Department of Surgery, The Israel Penn International Transplant Tumor Registry, The University of Cincinnati School of Medicine, OH 45267 0558, USA
    Transplantation 76:340-3. 2003
    ..One strategy is the use of organs from patients with a history of or active central nervous system (CNS) tumor...
  64. ncbi request reprint Gastric bypass in morbidly obese patients with chronic renal failure and kidney transplant
    J Wesley Alexander
    UC Surgeons, Inc Center for Surgical Weight Loss, University of Cincinnati, Cincinnati, OH 45267 0558, USA
    Transplantation 78:469-74. 2004
    ..Morbid obesity is also associated with an increased risk of complications and death in transplant patients and is often a cause for denial for access to transplantation...
  65. ncbi request reprint Hand-assisted laparoscopic living-donor nephrectomy as an alternative to traditional laparoscopic living-donor nephrectomy
    Joseph F Buell
    Division of Transplantation, The University of Cincinnati, Cincinnati, Ohio 45267, USA
    Am J Transplant 2:983-8. 2002
    ..Thus, similar to traditional laparoscopic donor nephrectomy, hand-assisted laparoscopic living-donor nephrectomy provides advantages over open donor nephrectomy without increasing costs...
  66. ncbi request reprint Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience
    Jennifer Trofe
    Israel Penn International Transplant Tumor Registry, Division of Transplantation, University of Cincinnati, Cincinnati, OH, USA
    Am J Transplant 5:775-80. 2005
    ..0001). Death risk was greater for multiple site PTLD and increasing age, and risks were additive. Univariate analysis identified increased death risk for those not receiving surgery, particularly allograft involvement alone...
  67. ncbi request reprint The influence of immunomodulatory diets on transplant success and complications
    J Wesley Alexander
    Department of Surgery, Division of Transplantation, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267 0558, USA
    Transplantation 79:460-5. 2005
    ..They also reduce cardiovascular complications and infections in humans...
  68. ncbi request reprint Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer
    Harry T Papaconstantinou
    Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9156, USA
    Dis Colon Rectum 47:1898-903. 2004
    ..The purpose of this study was to define the characteristics and survival patterns of transplant patients developing de novo colorectal cancer...
  69. ncbi request reprint Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma
    Jennifer Trofe
    Israel Penn International Transplant Tumor Registry, Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45267 0558, USA
    Transplantation 78:972-7. 2004
    ..There is no difference in recurrence rates for HD and NHL. The outcome for recurrent lymphoma is poor. The low risk of recurrence (10%) indicates that preexisting HD and NHL need not be an absolute contraindication to transplantation...
  70. ncbi request reprint Kidney transplantation: graft monitoring and immunosuppression
    Jonathan S Fisher
    Section of Transplantation, Department of Surgery, University of Tennessee, Room A 202, Memphis, Tennessee 38103, USA
    World J Surg 26:185-93. 2002
    ..Hopefully, these assays will serve as a guide for the reduction and possible removal of immunosuppressive agents from stable renal allograft recipients...
  71. ncbi request reprint Right donor nephrectomy: a comparison of hand-assisted transperitoneal and retroperitoneal laparoscopic approaches
    Joseph F Buell
    The University of Cincinnati, Cincinnati, OH, USA
    Transplantation 77:521-5. 2004
    ..We compare the anatomic and functional outcomes of right live-donor nephrectomy (LDN) using either a hand-assisted approach (HALDN) or a pure retroperitoneoscopic approach (RLDN) in two institutions...
  72. ncbi request reprint Incidental diagnosis of gastric cancer in transplant recipients improves patient survival
    Joseph F Buell
    Israel Penn International Transplant Registry, The University of Cincinnati, Cincinnati, Ohio 45267 0558, USA
    Surgery 132:754-8; discussion 758-60. 2002
    ..In the immunosuppressed transplant recipient population, little is known about the clinical staging and outcome of these compromised patients...
  73. ncbi request reprint Surgical techniques in right laparoscopic donor nephrectomy
    Joseph F Buell
    Department of Surgery, University of Cincinnati College of Medicine, OH 45267 0558, USA
    J Am Coll Surg 195:131-7. 2002
  74. ncbi request reprint Corticosteroid elimination in renal transplantation: pro
    E S Woodle
    Department of Surgery, Division of Transplantation, University of Cincinnati, 231 Bethesday Avenue, PO Box 670558, Cincinnati, OH 45267, USA
    Transplant Proc 34:1693. 2002
  75. ncbi request reprint Composite tissue allotransplantation: a review of relevant immunological issues for plastic surgeons
    Iain S Whitaker
    Department of Surgery, University of Louisville, 511 South Floyd Street, 320 MDR Building, Louisville, KY 40202, USA
    J Plast Reconstr Aesthet Surg 61:481-92. 2008
    ..With this in mind, the purpose of this manuscript is to provide plastic surgeons with a comprehensive and understandable review of key immunological principles relevant to composite tissue allotransplantation...
  76. ncbi request reprint Risk assessment of immunosuppressive therapy in facial transplantation
    Dalibor Vasilic
    Department of Surgery, University of Louisville, Louisville, KY 40202, USA
    Plast Reconstr Surg 120:657-68. 2007
    ..This review provides a comprehensive risk assessment for facial transplantation based on comparable data of immunosuppression, recipient health status, and composition and antigenicity of the transplanted tissue...
  77. doi request reprint De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population
    Yun Miao
    Division of Transplantation, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267 0558, USA
    Transplantation 87:1347-59. 2009
    ..The purpose of this study was to examine the influence of transplantation on the outcomes of individual cancers...
  78. ncbi request reprint The role of immunosuppression in lymphoma
    Jennifer Trofe
    Department of Surgery, University of Cincinnati, OH 45267 0558, USA
    Recent Results Cancer Res 159:55-66. 2002
    ..We review the major historical and recent immunosuppression trials to assess the impact of individual immunosuppressive agents and regimens on PTLD risk...
  79. doi request reprint Proteasome inhibition for antibody-mediated rejection
    Jason J Everly
    Department of Surgery, University of Cincinnati College of Medicine, Ohio, USA
    Curr Opin Organ Transplant 14:662-6. 2009
    ..The purpose of this review is to describe the biochemistry and physiology of proteasome inhibition and to discuss recent studies with proteasome inhibitor therapy in organ transplantation...
  80. ncbi request reprint Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study
    Joseph F Buell
    The University Hospital, Cincinnati, OH 45267 0004, USA
    Clin Transplant 19:102-9. 2005
    ..open donor nephrectomy (ODN) donors. This study utilized the SF-36 health survey, single-item health-related quality of life (HRQOL) score, and a functional assessment questionnaire ('Donor Survey')...
  81. ncbi request reprint A history of living donor transplantation: from twins to trades
    E S Woodle
    Division of Transplantation, Department of Surgery, University of Cincinnati, 231 Albert Sabin Way, PO Box 670558, Cincinnati, OH 45267, USA
    Transplant Proc 35:901-2. 2003
  82. ncbi request reprint Programmed cell death signaling via cell-surface expression of a single-chain antibody transgene
    S Kulkarni
    Department of Surgery, University of Chicago, Illinois 60637, USA
    Transplantation 69:1209-17. 2000
    ..Immobilized 5H7 delivers programmed cell death (PCD) signals to human lymphoid tumor cells as well as peripheral blood mononuclear cells...
  83. ncbi request reprint Programmed cell death
    E S Woodle
    Department of Surgery, University of Chicago, Illinois 60637, USA
    Transplantation 66:681-91. 1998
    ..This Overview provides a definition of PCD, a description of known PCD biochemical pathways, and finally a discussion of the implications of PCD in transplantation...
  84. ncbi request reprint MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature
    Meredith J Aull
    Division of Nephrology and Hypertension, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA
    Transplantation 75:225-8. 2003
    ..Mucosa-associated lymphoid tissue lymphoma (MALToma) is a Helicobacter pylori-related tumor of B-cell origin, the malignant potential for which remains to be defined in immunosuppressed patients...
  85. ncbi request reprint Laparoscopic liver resection
    Joseph F Buell
    Division of Transplantation, The University of Cincinnati, Cincinnati, OH 45267 0558, USA
    J Am Coll Surg 200:472-80. 2005
  86. ncbi request reprint West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death
    Debby DeSalvo
    Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267 0585, USA
    Transplantation 77:466-9. 2004
    ..Suggestions for the prevention, diagnosis, and treatment of West Nile virus infection in this patient population are described...
  87. ncbi request reprint An initial experience and evolution of laparoscopic hepatic resectional surgery
    Joseph F Buell
    Division of Transplantation, University of Cincinnati, OH 45267 0558, USA
    Surgery 136:804-11. 2004
    ..The use of minimally invasive procedures has revolutionized modern surgery. Only recently has laparoscopy been introduced for use in hepatic surgery...
  88. ncbi request reprint Liver transplantation for primary and metastatic hepatic malignancy: a single center experience
    Amit D Tevar
    Division of Transplantation, Department of Surgery, University of Cincinnati, Ohio 45267 0558, USA
    Surgery 139:535-41. 2006
  89. doi request reprint Transplant recipient's knowledge of posttransplant malignancy risk: implications for educational programs
    H Myron Kauffman
    Organ Procurement and Transplantation Network, United Network for Organ Sharing, Richmond, VA, USA
    Transplantation 85:928-33. 2008
  90. ncbi request reprint A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status
    Michael R Lucey
    University of Wisconsin Medical School, Madison, WI, USA
    Am J Transplant 5:1111-9. 2005
    ..While both calcineurin inhibitors were associated with excellent patient and graft survival, renal function, blood pressure and serum lipid levels were significantly better with tacrolimus treatment...
  91. ncbi request reprint Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis
    Rajiv D Poduval
    Division of Nephrology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA
    Transplantation 73:1166-9. 2002
    ..We present the first reported case of successful retransplantation after polyoma virus-induced renal allograft loss...
  92. ncbi request reprint The potential of paired donation programs: modeling and reality
    E Steve Woodle
    Am J Transplant 5:1787-8. 2005
  93. ncbi request reprint Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications
    Nicole A Weimert
    Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA
    Ther Drug Monit 29:141-9. 2007
    ..Quantification of IMPDH posttransplant may serve as a stable, surrogate PD marker of MPA-induced immunosuppression when combined with current PK and monitoring strategies...
  94. pmc BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy
    YiPing Chen
    Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    J Clin Virol 42:198-202. 2008
    ..The large T-antigen (T-ag) is the main regulatory protein of polyomaviruses that is expressed early in the viral cycle...
  95. pmc Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy
    YiPing Chen
    Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    J Virol 80:3495-505. 2006
    ..A high degree of epitope cross-recognition was present between BKV and corresponding JCV-specific CTLs, which indicates that the same population of cells is functionally effective against these two closely related viruses...
  96. ncbi request reprint Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry
    Meredith J Aull
    Department of Pharmacy, New York Presbyterian Hospital New York Weill Cornell Center, New York, NY, USA
    Transplantation 78:1676-82. 2004
    ..Published experiences with PTLD in cardiac transplant recipients are limited to relatively small single-center reports...
  97. ncbi request reprint United network for organ sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission data
    Joseph F Buell
    Transplantation 79:623. 2005